Orchid Chemicals to take over US-based Karalex Pharma

10 Jun 2010

1

Orchid Chemicals, the Chennai-based generic pharma major is all set to take over US based Karalex Pharma. The acquisition of the New Jersey headquartered generic marketing and sales services company is likely to be completed this month.

According to analysts the acquisition will help Orchid add $20 million in revenue from Karalex.
 
The transaction will close by this month subject to customary closing conditions.

With the acquisition, Orchid has established its presence in the front-end US market and will now be able to deliver its generic products directly to the US customers.

K Raghavendra Rao, managing director, Orchid Chemicals & Pharmaceuticals said the company was happy to have established its presence in the generic sales and marketing area with the acquisition. The acquisition would provide a strong commercial US-based sales capability to Orchid, paving the way for synergistic returns from is upcoming and long-term strategic generic pharmaceuticals pipeline comprising key first-to-file and Paragraph-IV products.

Business History Videos

History of hovercraft Part 3...

Today I shall talk a bit more about the military plans for ...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of hovercraft Part 2...

In this episode of our history of hovercraft, we shall exam...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Hovercraft Part 1...

If you’ve been a James Bond movie fan, you may recall seein...

By Kiron Kasbekar | Presenter: Kiron Kasbekar

History of Trams in India | ...

The video I am presenting to you is based on a script writt...

By Aniket Gupta | Presenter: Sheetal Gaikwad

view more